The Associated Press on MSN14d
Patient dies following muscular dystrophy gene therapy, Sarepta reportsIn 2023, Elevidys received expedited U.S. approval despite concerns from some Food and Drug Administration scientists about its effectiveness in treating Duchenne muscular dystrophy. It’s the first ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback